KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Exchange Rate Effect (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Exchange Rate Effect for 16 consecutive years, with -$273.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Exchange Rate Effect fell 2830.0% year-over-year to -$273.0 million, compared with a TTM value of -$91.0 million through Dec 2024, down 10.98%, and an annual FY2025 reading of $267.0 million, up 393.41% over the prior year.
  • Exchange Rate Effect was -$273.0 million for Q4 2024 at Thermo Fisher Scientific, down from $175.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $250.0 million in Q4 2022 and bottomed at -$273.0 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $2.9 million, with a median of -$2.5 million recorded in 2023.
  • The sharpest move saw Exchange Rate Effect soared 406.78% in 2020, then plummeted 2830.0% in 2024.
  • Year by year, Exchange Rate Effect stood at $102.0 million in 2020, then soared by 106.86% to $211.0 million in 2021, then grew by 18.48% to $250.0 million in 2022, then tumbled by 96.0% to $10.0 million in 2023, then tumbled by 2830.0% to -$273.0 million in 2024.
  • Business Quant data shows Exchange Rate Effect for TMO at -$273.0 million in Q4 2024, $175.0 million in Q3 2024, and -$15.0 million in Q2 2024.